Omeros Corporation OMER
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Omeros Corporation is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing small-molecule and protein therapeutics. It targets large-market opportunities as well as orphan indications, particularly in areas such as inflammation, coagulopathies, disorders of the central nerv…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees202
TickerOMER
Statistics
Market Cap$687.2M
Revenue (TTM)$9.2M
Net Income-$3.4M
Net Margin-36.3%
EPS$-0.05
P/E8.93
P/S74.47
P/B-9.92
EV/EBITDA-7.95
ROE2.8%
Dividend Yield—
Price$9.54
Data: Twelve Data · Revenue = mcap / P/S